Nanjing King-friend Biochemical Pharmaceutical Co Ltd
SSE:603707
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
Revenue
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
N
|
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
SSE:603707
|
Revenue
¥4B
|
CAGR 3-Years
13%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Revenue
¥10.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Revenue
¥9.7B
|
CAGR 3-Years
14%
|
CAGR 5-Years
16%
|
CAGR 10-Years
22%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Revenue
¥22.3B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
7%
|
CAGR 10-Years
14%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Revenue
¥39.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Revenue
¥2.5B
|
CAGR 3-Years
24%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
See Also
What is Nanjing King-friend Biochemical Pharmaceutical Co Ltd's Revenue?
Revenue
4B
CNY
Based on the financial report for Sep 30, 2023, Nanjing King-friend Biochemical Pharmaceutical Co Ltd's Revenue amounts to 4B CNY.
What is Nanjing King-friend Biochemical Pharmaceutical Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
20%
Over the last year, the Revenue growth was 7%. The average annual Revenue growth rates for Nanjing King-friend Biochemical Pharmaceutical Co Ltd have been 13% over the past three years , 20% over the past five years .